CLINICAL_TRIALS ClinicalTrials.gov record update

A Feasibility Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and in Maintenance for Resectable Malignant Pleural Mesothelioma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03228537
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:29:00.186941+00:00
Published At: 2024-03-05T00:00:00+00:00
Record Updated At: 2025-11-10
Results Posted At: 2024-03-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Biphasic Mesothelioma", "Epithelioid Mesothelioma", "Stage I Pleural Malignant Mesothelioma AJCC v7", "Stage IA Pleural Malignant Mesothelioma AJCC v7", "Stage IB Pleural Malignant Mesothelioma AJCC v7", "Stage II Pleural Malignant Mesothelioma AJCC v7", "Stage III Pleural Malignant Mesothelioma AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-11-10"
protocolSection.identificationModule.nctId: "NCT03228537"
protocolSection.identificationModule.officialTitle: "A Feasibility Trial of Neoadjuvant Cisplatin-Pemetrexed With Atezolizumab in Combination and in Maintenance for Resectable Malignant Pleural Mesothelioma"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2024-03-05"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.